The U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs.
Healthcare
FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
Source: FDA Press Releases — US Government, Public Domain